Name: How Much Will the Covid-19 Vaccine Cost? | WSJ
Uploaded: 2021-05-30T12:10:00.000Z
Duration: 5 min 57 s
Description: VoiceTubeの動画で発音を聞きながら英語表現を覚えよう！学べる英語：

- [Announcer] A Corona virus vaccine is seen

Some companies have said that a dose could sell

for as little as a few bucks to as much as $25.

And that vaccines may actually be available fairly quickly

by industry standards, meaning less than two years,

- [Announcer] Of more than 160 groups racing

a handful entered the final testing stage

That's much faster than the usual process,

And that's in part thanks to US government money.

The administration handed out more than $10 billion

- There's an expectation on the public's part that the drug,

because it's been funded partially by tax payer money,

- [Announcer] But investors have also poured funds

Getting it from the lab to clinic can cost billions

of dollars and not all of the companies that

are developing vaccines will end up with a viable product.

- Of all of the vaccines that start human testing,

at Tufts Center for the Study of Drug Development,

which receives grants from the pharmaceutical industry.

He says vaccine R&D is something few companies can afford.

- Not a lot of companies actually invest in this

One of them is the poor likelihood of success

- [Announcer] But in the case of the COVID-19 pandemic,

government money is taking away a lot of that risk

by funding, vaccine research and development

and signing contracts to buy the vaccines before

Two government deals with Moderna and Pfizer would secure

as many as 200 million doses by January next year.

And that would mean both vaccines would be free of charge

received additional funds for manufacturing

Michael Kinch is a biochemistry professor

- Under what conditions, what the temperatures and humidity

that certain conditions ruin a batch of vaccine.

- There's also a parallel scramble to secure billions

of medical grade vials and syringes that are just

- Certainly there are just 7 billion people,

you're talking about a monumental logistics challenge

of being able to create double digit billions

- Manufacturers of glass vials have estimated

that worldwide demand because of the pandemic

will increase by 2 billion over the next two years.

Since most of the medical supplies are sourced overseas,

the US government is giving American glass-makers

Some Americans are hesitant about taking a COVID-19 vaccine

because of concerns that development is being rushed.

To allay those concerns, several industry rivals

are planning a joint pledge to not seek regulatory approval

until the shots are proven to be safe and effective.

Despite the hurdles, some companies are joining

the crowded race because they already have

For instance, Novavax says it makes business sense

a promising flu vaccine to develop one for COVID-19.

Plus financial backing from not just the US government,

but also various countries and nonprofits

have also given companies more of an incentive to chip

字幕リスト動画再生

How Much Will the Covid-19 Vaccine Cost? | WSJ

vulnerable

pandemic

effective

ruin